Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
VillageMD runs primary care clinics and partners with doctors and insurers to deliver value-based care, where the goal is keeping patients healthy rather than billing for more visits.
VillageMD is a primary care company that runs doctors' offices and helps physicians move to value-based care, a model where a health plan pays a fixed amount per patient rather than paying for each test and visit. The point is to flip the incentive: if the clinic makes money by keeping people healthy, it has a reason to invest in prevention and to catch problems early instead of cashing in on more procedures. Most patients meet VillageMD as a regular doctor's office, often under a brand like Village Medical, and many clinics sit inside or right next to a Walgreens pharmacy.
The money comes from health insurers, government programs like Medicare, and the patients themselves, but the important shift is who carries the risk. VillageMD takes on "capitation" contracts โ insurers hand it a set fee per patient for their care โ and it keeps the leftover money if patients stay healthy and costs stay low. That is the engine and also the trap: the same deal that rewards good medicine can blow up if patients get sicker and costlier than expected. It lands somewhere between a doctor's office and an insurance company, which is exactly why it is so exposed when costs run hot. VillageMD's big move was its tie-up with Walgreens Boots Alliance Walgreens Boots Alliance, which spent billions building a majority stake starting in 2020 and later took full ownership. For a while the plan looked elegant: put clinics next to drugstores, serve the same aging customers, and funnel them into value-based care. It did not go smoothly. The clinics grew fast but lost money, Walgreens absorbed huge writedowns, and the industry as a whole scrambled after Medicare's 2024 rate changes squeezed the economics of these plans. In 2025 Walgreens agreed to sell VillageMD to a private equity firm, ending the pharmacy giant's unhappy detour into running doctors' offices.
The story captures both the promise and the mess of value-based care. Done well, it can mean fewer hospital trips and better care for people with chronic conditions. Done badly, it is a business where you take on the risk of a population's health, and that risk can be far bigger than a clinic's thin margin. VillageMD's future now depends less on foot traffic next to a pharmacy counter and more on whether its clinics can keep patients well enough to beat the fees they are paid.
Saved answer ยท last researched 15 Nov 2026